{"id":"W4416603446","doi":"10.5256/f1000research.144734.r173282","title":"Referee report. For: The identification of high-preforming antibodies for Ubiquilin-2 for use in Western Blot, immunoprecipitation, and immunofluorescence [version 1; peer review: 1 approved]","year":2023,"lang":"en","type":"article","venue":"Faculty of 1000 Research Ltd","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Genentech; Government of Canada; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Mitacs; Ontario Genomics; Genome Canada; Bayer; Motor Neurone Disease Association; Pfizer; Bristol-Myers Squibb","keywords":"Immunofluorescence; Identification (biology); Antibody; Indirect immunofluorescence","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005595667,0.0007931571,0.001265184,0.003357817,0.003114347,0.002498468,0.002642859,0.004642974,0.5343803],"category_scores_gemma":[0.05736044,0.0005424176,0.001082025,0.002829684,0.0006963388,0.00228467,0.00261966,0.00347388,0.2931034],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003938614,"about_ca_system_score_gemma":0.004308119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03036455,"about_ca_topic_score_gemma":0.04558164,"domain_scores_codex":[0.9960861,0.0005599085,0.000501752,0.0004980316,0.002064488,0.0002896339],"domain_scores_gemma":[0.9387931,0.008963156,0.0009622783,0.00302499,0.04631086,0.001945655],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001138807,0.00001242857,0.00004509509,0.00004544011,0.000002446287,0.00004299623,0.00001978684,0.000009706576,0.0001570409,0.0003706247,0.9954097,0.003873351],"study_design_scores_gemma":[0.0000235693,0.00001595751,0.001222158,0.00007758168,0.000009920117,0.000117739,0.00009787285,0.00008930073,0.0004103059,0.001269817,0.9966324,0.00003333168],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"commentary","genre_scores_codex":[0.001371785,0.003781972,0.01073612,0.3344408,0.3751296,0.002543856,0.06670057,0.006701401,0.1985939],"genre_scores_gemma":[0.007360622,0.002573494,0.006745918,0.05665291,0.03385813,0.001149917,0.01860667,0.002055651,0.8709968],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.9944043,"threshold_uncertainty_score":0.66415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06951730187943153,"score_gpt":0.3799372533053639,"score_spread":0.3104199514259324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}